Evidence map›Paper›PMID 26176555›Full record

ArticleAccounts of chemical research2015

Toward the synthesis of more reactive S = 2 non-heme oxoiron(IV) complexes.

Mayank Puri, Lawrence Que

Abstract read
In one paragraph

Article in Accounts of chemical research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 77 papers.

0numbers the graph read from it
0cells of the map it votes in
77citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

77 citing papers in PubMed.

  1. Article
  2. Article
  3. Metal-metalChemical science · 2026
    Article
  4. Review
  5. Review
  6. Article
  7. Metal-α-Helix Peptide Frameworks.Journal of the American Chemical Society · 2025
    Article
  8. Experimental electronic structures of the FeProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  9. 10-Fold Increase in Hydrogen Atom Transfer Reactivity for a Series ofJournal of the American Chemical Society · 2025
    Article
  10. Article
  11. Experimental Definition of theJournal of the American Chemical Society · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. NMR and Mössbauer Studies Reveal a Temperature-Dependent Switch fromJournal of the American Chemical Society · 2024
    Article
  18. Article
  19. Article
  20. Nonheme FeInorganic chemistry · 2023
    Article

17 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Mayank PuriDepartment of Chemistry and Center for Metals in Biocatalysis, University of Minnesota, Minneapolis, Minnesota 55455, United States.
Lawrence QueDepartment of Chemistry and Center for Metals in Biocatalysis, University of Minnesota, Minneapolis, Minnesota 55455, United States.

Funding

Synthetic Models and Spectroscopy of Nonheme Diiron EnzymesR01GM038767 · NIGMS · UNIVERSITY OF MINNESOTA TWIN CITIES · PI QUE, LAWRENCE · 1987 to 2018
$5.8M
NIGMS NIH HHS GM38767NIGMS NIH HHS R01 GM038767
6 · The paper itself

Abstract

2003 marked a banner year in the bioinorganic chemistry of mononuclear non-heme iron enzymes. The first non-heme oxoiron(IV) intermediate (called J) was trapped and characterized by Bollinger and Krebs in the catalytic cycle of taurine dioxygenase (TauD), and the first crystal structure of a synthetic non-heme oxoiron(IV) complex was reported by Münck, Nam, and Que. These results stimulated inorganic chemists to synthesize related oxoiron(IV) complexes to shed light on the electronic structures and spectroscopic properties of these novel intermediates and gain mechanistic insights into their function in biology. All of the biological oxoiron(IV) intermediates discovered since 2003 have an S = 2 ground spin state, while over 90% of the 60 or so synthetic oxoiron(IV) complexes reported to date have an S = 1 ground spin state. This difference in electronic structure has fueled an interest to more accurately model these enzymatic intermediates and synthesize S = 2 oxoiron(IV) complexes. This Account follows up on a previous Account (Acc. Chem. Res. 2007, 40, 493) that provided a perspective on the early developments in this field up to 2007 and details our group's efforts in the development of synthetic strategies to obtain oxoiron(IV) complexes with an S = 2 ground state. Upon inspection of a qualitative d-orbital splitting diagram for a d(4) metal-oxo center, it becomes evident that the key to achieving an S = 2 ground state is to decrease the energy gap between the dx(2)-y(2) and dxy orbitals. Described below are two different synthetic strategies we used to accomplish this goal. The first strategy took advantage of the realization that the dx(2)-y(2) and dxy orbitals become degenerate in a C3-symmetric ligand environment. Thus, by employing bulky tripodal ligands, trigonal-bipyramidal S = 2 oxoiron(IV) complexes were obtained. However, substrate access to the oxoiron(IV) center was hindered by the bulky ligands, and the complexes showed limited ability to cleave substrate C-H bonds. The second strategy entailed introducing weaker-field equatorial ligands in six-coordinate oxoiron(IV) complexes to decrease the dx(2)-y(2)/dxy energy gap to the point where the S = 2 ground state is favored. These pseudo-octahedral S = 2 oxoiron(IV) complexes exhibit high H-atom transfer reactivity relative to their S = 1 counterparts and shed light on the role that the spin state may play in these reactions. Among these complexes is a highly reactive species that to date represents the closest electronic and functional model of the enzymatic intermediate, TauD-J.

Indexed as

CatalysisCoordination ComplexesCrystallography, X-RayHydrogenIronLigandsMixed Function OxygenasesMolecular ConformationOxygenCoordination ComplexesHydrogenIronLigandsMixed Function OxygenasesOxygentaurine-alpha-ketoglutarate dioxygenase

Identifiers

PMID26176555
PMCPMC4542507

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.